Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

GSK: 'rapid progress' on swine flu vaccine

  • Comment

Drugs company GlaxoSmithKline has said it is making “rapid progress” on its swine flu vaccine.

Total doses ordered by governments worldwide so far total 291 million. The company aims to make the vaccine for the H1N1 swine flu virus available from September onwards with shipping expected in the second half of 2009 and early 2010.

Although Glaxo is confident the first vaccine will be available on schedule, it is unsure how quickly it can be produced to fulfil orders.

The drug maker is one of several pharma firms commissioned by the World Health Organisation to produce a vaccine for the pandemic virus and has now agreed contracts with 25 countries.

The UK government has ordered 132 million doses - two per person - from both Glaxo and another producer Baxter, worth £155.4m over four years.


  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions.

Links may be included in your comments but HTML is not permitted.